🇺🇸 Lacidofil in United States

76 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 27 March 2025 – 27 March 2026
• Total reports: 76

Most-reported reactions

1. Leukopenia — 9 reports (11.84%)
2. Pneumonia — 9 reports (11.84%)
3. Urinary Tract Infection — 9 reports (11.84%)
4. Interstitial Lung Disease — 8 reports (10.53%)
5. Product Use In Unapproved Indication — 8 reports (10.53%)
6. Acute Respiratory Failure — 7 reports (9.21%)
7. Covid-19 — 7 reports (9.21%)
8. Off Label Use — 7 reports (9.21%)
9. Pulmonary Embolism — 7 reports (9.21%)
10. Constipation — 5 reports (6.58%)

Source database →

Frequently asked questions

Is Lacidofil approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Lacidofil in United States?

Dr. Stephen Freedman is the originator. The local marketing authorisation holder may differ — check the official source linked above.